Corcept Therapeutics

CORTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.974 B

$110.77 +2.61%

Close of 7 Aug 2026

Revenue

$761.4M

#1683 by revenue

Earnings

$99.7M

#1318 by earnings

Shares outstanding

108,098,397

Latest filing cover page

P/E ratio

120.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#28Arrowhead PharmaceuticalsARWR$12.4B
#29Biomarin PharmaceuticalBMRN$12.3B
#30Corcept TherapeuticsCORT$12.0B
#31Madrigal PharmaceuticalsMDGL$11.8B
#32AbivaxABVX$11.3B

Where these numbers come from

Share counts and financials for Corcept Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.